The application of nanotechnology in agriculture has increased rapidly. However, the fate and effects of various nanoparticles on the soil, plants, and humans are not fully understood. Reports indicate that nanoparticles exhibit positive and negative impacts on biota due to their size, surface property, concentration within the system, and species or cell type under test. In plants, nanoparticles are translocated either by apoplast or symplast pathway or both. Also, it is not clear whether the nanoparticles entering the plant system remain as nanoparticles or are biotransformed into ionic forms or other organic compounds. Controversial results on the toxicity effects of nanomaterials on the plant system are available. In general, the nanomaterial toxicity was exerted by producing reactive oxygen species, leading to damage or denaturation of various biomolecules. The intensity of cyto- and geno-toxicity depends on the physical and chemical properties of nanoparticles. Based on the literature survey, it is observed that the effects of nanoparticles on the growth, photosynthesis, and primary and secondary metabolism of plants are both positive and negative; the response of these processes to the nanoparticle was associated with the type of nanoparticle, the concentration within the tissue, crop species, and stage of growth. Future studies should focus on addressing the key knowledge gaps in understanding the responses of plants to nanoparticles at all levels through global transcriptome, proteome, and metabolome assays and evaluating nanoparticles under field conditions at realistic exposure concentrations to determine the level of entry of nanoparticles into the food chain and assess the impact of nanoparticles on the ecosystem.
We explored whether copper nanoparticles (CuNPs) can function as an efflux pump inhibitor and as an anti-biofilm agent. Our results showed that at 0.5× (0.065 mM) Minimum Inhibitory Concentration (MIC), CuNPs exhibited remarkable efflux inhibitory effect in wild type strains of both Staphylococcus aureus and Pseudomonas aeruginosa and less but significant efflux inhibitory effect against MRSA and drug resistant mutant strains of Staphylococcus aureus. At 1× MIC (0.13 mM) concentration, they significantly inhibited monoculture biofilms formed by Staphylococcus aureus and Pseudomonas aeruginosa. Membrane permeability, membrane integrity and confocal imaging provided insight into the mechanism of the antibacterial effect of CuNPs. Efflux inhibition and antibacterial effect of CuNPs was partly mediated by particle effect and partly by ion effect. A novel efflux pump inhibitory role for CuNPs is reported in our study. Proof of concept experiments revealed that CuNPs could reverse the MIC of the mutant Staphylococci aureus strain for ciprofloxacin by 4 fold (from 64 μg ml−1 to 16 μg ml−1), hence our study reveals that CuNPs could be potentially employed as bacterial adjuvants to curtail Multi Drug Resistant (MDR) bacteria.
1 September 2014 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
In this study, a facile method to synthesize non-toxic copper sulfide nanoparticles was reported, and the antibacterial activity of the nanoparticles in infected zebrafish was evaluated. Transmission electron microscopy showed that the CuS NPs are spherical in shape with a size range from 10 to 25 nm. FTIR spectra revealed that the CuS NPs were stabilized by N-lauryltyramine. CuS NPs exhibit very good antibacterial activity against Gram-negative and Gram-positive bacteria, and the minimum inhibitory concentration was determined as 12.5 μM. In vitro mechanistic studies revealed that CuS NPs kill the bacteria by damaging their cell membranes and producing reactive oxygen species. Therapeutic activity of CuS NPs was tested in bacteria-infected zebrafish. The route of administration of CuS NPs was via an injection and medicated bath. Both routes of drug administration were suitable to cure the fish from bacterial infection. Bacterial colony count assay revealed that the CuS NPs depleted the infectious bacteria from the fish body within 24 h. Strikingly, CuS NPs in concentration eight times than the MIC did not show toxicity in the liver and brain of zebrafish. Moreover, the NPs exhibited good hemocompatibility with human red blood cells. Our study demonstrated for the first time that CuS NPs are a safe antibacterial agent, and medicated bath with zebrafish is a hassle-free model for testing the antibacterial activity of nanoparticles.
1 November 2016 in Materials Science and Engineering: C